Bio-Rad Laboratories BIO Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's total equity?
- Bio-Rad Laboratories (BIO) reported total equity of $6.85B in Q1 2026.
- How has Bio-Rad Laboratories's total equity changed year-over-year?
- Bio-Rad Laboratories's total equity increased by 2.6% year-over-year, from $6.68B to $6.85B.
- What is the long-term trend for Bio-Rad Laboratories's total equity?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's total equity has grown at a -5.5% compound annual growth rate (CAGR), from $9.89B to $7.45B.
- What does total equity mean?
- The total net value of the company belonging to the shareholders after all debts are paid.
- How do you interpret total equity?
- Growth in equity generally signals value creation, while a decline may indicate losses or aggressive share buybacks.
- How does total equity compare across companies?
- The standard denominator for Return on Equity (ROE) calculations across all sectors.